Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - Dehydrogenase - PHGDH-IN-3

PHGDH-IN-3

CAS No. 2893778-31-7

PHGDH-IN-3( —— )

Catalog No. M36500 CAS No. 2893778-31-7

PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 227 In Stock
10MG 337 In Stock
25MG 541 In Stock
50MG 709 In Stock
100MG 918 In Stock
200MG Get Quote In Stock
500MG 1841 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    PHGDH-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 2.8 μM against PHGDH, and it can be used in cancer research.
  • Description
    PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor. PHGDH-IN-3 inhibits PHGDH with an IC50 value of 2.8 μM. PHGDH-IN-3 can be used for the research of cancer.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Balb/c nude mice Dosage:12.5, 25, 50 mg/kg Administration:Intraperitoneal (i.p.); once daily for consecutive 31 days Result:Exhibited an in vivo anti-tumor effect and significantly delayed the tumor growth.Significantly abated the tumor weights of mice at 25 mg/ kg.
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Dehydrogenase
  • Recptor
    Dehydrogenase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2893778-31-7
  • Formula Weight
    495.55
  • Molecular Formula
    C24H18FN3O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (201.80 mM; Ultrasonic (<70°C)
  • SMILES
    N(C(=O)C1=CC=C(S(NC2=CC(C(C)=O)=CC=C2)(=O)=O)C=C1)C3=NC(=CS3)C4=CC(F)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Dingding Gao, et al. Discovery of Novel Drug-like PHGDH Inhibitors to Disrupt Serine Biosynthesis for Cancer Therapy. J Med Chem. 2023 Jan 12;66(1):285-305.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • IMB-XMA0038

    IMB-XMA0038 is a novel inhibitor targeting Mycobacterium tuberculosis aspartate semialdehyde dehydrogenase with antimicrobial activity for use in tuberculosis research.

  • GSK1940029

    GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.

  • GSK2837808A

    GSK2837808A is a potent and selective inhibitor of lactate dehydrogenase A (LDHA) (IC50s: 1.9 and 14 nM for LDHA and LDHB, respectively).

Sign In Join Free